Clinical trials in pediatric ALS: a TRICALS feasibility study
dc.date.accessioned | 2023-02-09T18:18:57Z | |
dc.date.available | 2023-02-09T18:18:57Z | |
dc.date.created | 2022-03-08T12:12:46Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Kliest, Tessa van Eijk, Ruben P. A. Al-Chalabi, Ammar Albanese, Alberto Andersen, Peter M. Amador, Maria Del Mar Bråthen, Geir Brunaud-Danel, Veronique Brylev, Lev Camu, William de Carvalho, Mamede Cereda, Cristina Cetin, Hakan Chaverri, Delia Chiò, Adriano Corcia, Philippe Couratier, Philippe De Marchi, Fabiola Desnuelle, Claude van Es, Michael A. Esteban, Jesús Filosto, Massimiliano Redondo, Alberto García Grosskreutz, Julian Hanemann, Clemens O. Holmøy, Trygve Høyer, Helle Ingre, Caroline Koritnik, Blaz Kuzma-Kozakiewicz, Magdalena Lambert, Thomas Leigh, Peter N. Lunetta, Christian Mandrioli, Jessica McDermott, Christopher J. Meyer, Thomas Mora, Jesus S. Petri, Susanne Povedano, Mónica Reviers, Evy Riva, Nilo Roes, Kit C. B. Rubio, Miguel Á. Salachas, François Sarafov, Stayko Sorarù, Gianni Stevic, Zorica Svenstrup, Kirsten Møller, Anette Torvin Turner, Martin R. Van Damme, Philip van Leeuwen, Lucie A. G. Varona, Luis Costa, Juan F. Vázquez Weber, Markus Hardiman, Orla Berg, Leonard H. van den . Clinical trials in pediatric ALS: a TRICALS feasibility study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2022 | |
dc.identifier.uri | http://hdl.handle.net/10852/99858 | |
dc.description.abstract | Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA).Objective: To assess the feasibility of clinical studies on the effect of therapy in children ( | |
dc.description.abstract | Clinical trials in pediatric ALS: a TRICALS feasibility study | |
dc.language | EN | |
dc.publisher | Informa healthcare | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Clinical trials in pediatric ALS: a TRICALS feasibility study | |
dc.title.alternative | ENEngelskEnglishClinical trials in pediatric ALS: a TRICALS feasibility study | |
dc.type | Journal article | |
dc.creator.author | Kliest, Tessa | |
dc.creator.author | van Eijk, Ruben P. A. | |
dc.creator.author | Al-Chalabi, Ammar | |
dc.creator.author | Albanese, Alberto | |
dc.creator.author | Andersen, Peter M. | |
dc.creator.author | Amador, Maria Del Mar | |
dc.creator.author | Bråthen, Geir | |
dc.creator.author | Brunaud-Danel, Veronique | |
dc.creator.author | Brylev, Lev | |
dc.creator.author | Camu, William | |
dc.creator.author | de Carvalho, Mamede | |
dc.creator.author | Cereda, Cristina | |
dc.creator.author | Cetin, Hakan | |
dc.creator.author | Chaverri, Delia | |
dc.creator.author | Chiò, Adriano | |
dc.creator.author | Corcia, Philippe | |
dc.creator.author | Couratier, Philippe | |
dc.creator.author | De Marchi, Fabiola | |
dc.creator.author | Desnuelle, Claude | |
dc.creator.author | van Es, Michael A. | |
dc.creator.author | Esteban, Jesús | |
dc.creator.author | Filosto, Massimiliano | |
dc.creator.author | Redondo, Alberto García | |
dc.creator.author | Grosskreutz, Julian | |
dc.creator.author | Hanemann, Clemens O. | |
dc.creator.author | Holmøy, Trygve | |
dc.creator.author | Høyer, Helle | |
dc.creator.author | Ingre, Caroline | |
dc.creator.author | Koritnik, Blaz | |
dc.creator.author | Kuzma-Kozakiewicz, Magdalena | |
dc.creator.author | Lambert, Thomas | |
dc.creator.author | Leigh, Peter N. | |
dc.creator.author | Lunetta, Christian | |
dc.creator.author | Mandrioli, Jessica | |
dc.creator.author | McDermott, Christopher J. | |
dc.creator.author | Meyer, Thomas | |
dc.creator.author | Mora, Jesus S. | |
dc.creator.author | Petri, Susanne | |
dc.creator.author | Povedano, Mónica | |
dc.creator.author | Reviers, Evy | |
dc.creator.author | Riva, Nilo | |
dc.creator.author | Roes, Kit C. B. | |
dc.creator.author | Rubio, Miguel Á. | |
dc.creator.author | Salachas, François | |
dc.creator.author | Sarafov, Stayko | |
dc.creator.author | Sorarù, Gianni | |
dc.creator.author | Stevic, Zorica | |
dc.creator.author | Svenstrup, Kirsten | |
dc.creator.author | Møller, Anette Torvin | |
dc.creator.author | Turner, Martin R. | |
dc.creator.author | Van Damme, Philip | |
dc.creator.author | van Leeuwen, Lucie A. G. | |
dc.creator.author | Varona, Luis | |
dc.creator.author | Costa, Juan F. Vázquez | |
dc.creator.author | Weber, Markus | |
dc.creator.author | Hardiman, Orla | |
dc.creator.author | Berg, Leonard H. van den | |
cristin.unitcode | 185,53,82,0 | |
cristin.unitname | Klinikk for indremedisin og lab fag | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 2008264 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration&rft.volume=&rft.spage=&rft.date=2022 | |
dc.identifier.jtitle | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | |
dc.identifier.volume | 23 | |
dc.identifier.issue | 7-8 | |
dc.identifier.startpage | 481 | |
dc.identifier.endpage | 488 | |
dc.identifier.doi | https://doi.org/10.1080/21678421.2021.2024856 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 2167-8421 | |
dc.type.version | PublishedVersion | |
dc.relation.project | HSØ/2021097 | |
dc.relation.project | STHF/8208.03 + 8208.04 | |
dc.relation.project | ALSNORGE/8208.05 |
Files in this item
Appears in the following Collection
-
Institutt for klinisk medisin [10814]
-
CRIStin høstingsarkiv [31446]